Roche (RHHBY) Stock Price, News & Analysis

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Key Stats

• Today's Range: $40.10 to $40.80
• 50-Day Range: $37.57 to $41.44
• 52-Week Range: $34.10 to $44.31
• Volume: 564,774 shs
• Average Volume: 1.37 million shs
• Market Capitalization: $255.29 billion
• P/E Ratio: N/A
• Dividend Yield: 2.17%
• Price Target: N/A
• Consensus Rating: Moderate Buy

RHHBY Stock Analysis - Frequently Asked Questions

How have RHHBY shares performed this year?

Roche's stock was trading at $34.88 on January 1st, 2025. Since then, RHHBY shares have increased by 15.0% and is now trading at $40.12.

Does Roche have any subsidiaries?

Roche subsidiaries include Inflazome, Stratos Genomics, Promedior, Spark Therapeutics, Tusk Therapeutics, Flatiron Health, Ignyta, and others.

Who are Roche's major shareholders?

Top institutional shareholders of Roche include Saratoga Research & Investment Management (0.03%), Boston Common Asset Management LLC (0.01%), OLD National Bancorp IN and Bard Financial Services Inc..

How do I buy shares of Roche?

Shares of RHHBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 8/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Large Cap Pharma
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:RHHBY
• CIK: N/A
• Web: www.roche.com
• Phone: (161) 688-1111
• Fax: 41-0-61-691-9391
• Employees: 103,249
• Year Founded: 1896

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 14.28
• P/E Growth: 3.15
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.85
• Current Ratio: 1.48
• Quick Ratio: 1.20

Sales & Book Value

• Annual Sales: $68.73 billion
• Price / Sales: 3.71
• Cash Flow: $3.24 per share
• Price / Cash Flow: 12.37
• Book Value: $6.46 per share
• Price / Book: 6.21

Miscellaneous

• Outstanding Shares: 6,363,210,000
• Free Float: N/A
• Market Cap: $255.29 billion
• Optionable: Not Optionable
• Beta: 0.46